AAGYLUR
Live / Applied — First extension granted (statement of use) (as of 10 Sept 2025)
What this means for you
Not registered yet, but its 05 Sept 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98165574
- Mark type
- Stylized text
- Filed
- 05 Sept 2023
- Published for opposition
- 21 Jan 2025
- Attorney of record
- Mary Frances Love
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations containing penicillamine; pharmaceutical preparations for the treatment of Wilson's disease
Owner
- Cycle Pharmaceuticals Ltd, CAMBRIDGE, GB
- Cycle Pharmaceuticals Ltd, CAMBRIDGE, GB
Prosecution history
- 11 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Sept 2025 — SOU EXTENSION 1 GRANTED
- 10 Sept 2025 — SOU EXTENSION 1 FILED
- 10 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 21 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Jan 2025 — PUBLISHED FOR OPPOSITION
- 15 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 31 Dec 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Nov 2024 — ASSIGNED TO EXAMINER
- 26 Jun 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 26 Jun 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 26 Jun 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 26 Mar 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 26 Mar 2024 — NON-FINAL ACTION E-MAILED